AbbVie Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 14,583 million compared to USD 13,959 million a year ago. Net income was USD 924 million compared to USD 766 million a year ago. Diluted earnings per share from continuing operations was USD 0.51 compared to USD 0.42 a year ago.
For the six months, sales was USD 28,121 million compared to USD 26,969 million a year ago. Net income was USD 5,414 million compared to USD 4,319 million a year ago. Diluted earnings per share from continuing operations was USD 3.03 compared to USD 2.41 a year ago.